Bibliography

Found 9 results

Filters: Author is Anya Umlauf [Clear All Filters]

2016

Fazeli PL, Moore D, Franklin D, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman B, Sacktor N, et al. Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res. 2016 ;14(4):324-30.

Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Batki IB, Moore D, Masliah E, Achim C. Methamphetamine dependence is associated with cerebral microgliosis in HIV-1 infected adults. Journal of Neurovirology. 2016 ;22.

2015

Bryant AK, Ellis RJ, Umlauf A, Gouaux B, Soontornniyomkij V, Letendre S, Achim C, Masliah E, Grant I, Moore D. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 ;29(3):323-30.

Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman B, McArthur JC, McCutchan JA, et al. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol. 2015 ;21(5):559-67.

2014

Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan JA, Duarte NA, Atkinson JH, Grant I, Ellis RJ. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Res. 2014 ;218(1-2):201-8.

Soontornniyomkij V, Umlauf A, Chung SA, Cochran ML, Soontornniyomkij B, Gouaux B, Toperoff W, Moore D, Masliah E, Ellis RJ, et al. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 ;28(9):1297-306.

Marquine MJ, Umlauf A, Rooney AS, Fazeli PL, Gouaux B, Woods SPaul, Letendre S, Ellis RJ, Grant I, Moore D. The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014 ;65(2):190-7.

2013

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

2012

Soontornniyomkij V, Moore D, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, et al. Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS [Internet]. 2012 ;26(18):2327-2335. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23018443